Literature DB >> 19126760

Endocannabinoid-mediated control of synaptic transmission.

Masanobu Kano1, Takako Ohno-Shosaku, Yuki Hashimotodani, Motokazu Uchigashima, Masahiko Watanabe.   

Abstract

The discovery of cannabinoid receptors and subsequent identification of their endogenous ligands (endocannabinoids) in early 1990s have greatly accelerated research on cannabinoid actions in the brain. Then, the discovery in 2001 that endocannabinoids mediate retrograde synaptic signaling has opened up a new era for cannabinoid research and also established a new concept how diffusible messengers modulate synaptic efficacy and neural activity. The last 7 years have witnessed remarkable advances in our understanding of the endocannabinoid system. It is now well accepted that endocannabinoids are released from postsynaptic neurons, activate presynaptic cannabinoid CB(1) receptors, and cause transient and long-lasting reduction of neurotransmitter release. In this review, we aim to integrate our current understanding of functions of the endocannabinoid system, especially focusing on the control of synaptic transmission in the brain. We summarize recent electrophysiological studies carried out on synapses of various brain regions and discuss how synaptic transmission is regulated by endocannabinoid signaling. Then we refer to recent anatomical studies on subcellular distribution of the molecules involved in endocannabinoid signaling and discuss how these signaling molecules are arranged around synapses. In addition, we make a brief overview of studies on cannabinoid receptors and their intracellular signaling, biochemical studies on endocannabinoid metabolism, and behavioral studies on the roles of the endocannabinoid system in various aspects of neural functions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19126760     DOI: 10.1152/physrev.00019.2008

Source DB:  PubMed          Journal:  Physiol Rev        ISSN: 0031-9333            Impact factor:   37.312


  556 in total

1.  Distinct endocannabinoid control of GABA release at perisomatic and dendritic synapses in the hippocampus.

Authors:  Sang-Hun Lee; Csaba Földy; Ivan Soltesz
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

Review 2.  The endocannabinoid system: role in energy regulation.

Authors:  Thomas F Gamage; Aron H Lichtman
Journal:  Pediatr Blood Cancer       Date:  2012-01       Impact factor: 3.167

Review 3.  Regulation of endocannabinoid release by G proteins: a paracrine mechanism of G protein-coupled receptor action.

Authors:  Pál Gyombolai; Dorottya Pap; Gábor Turu; Kevin J Catt; György Bagdy; László Hunyady
Journal:  Mol Cell Endocrinol       Date:  2011-11-02       Impact factor: 4.102

4.  Delayed preattentional functioning in early psychosis patients with cannabis use.

Authors:  Nicole Pesa; Daniel F Hermens; Robert A Battisti; Manreena Kaur; Ian B Hickie; Nadia Solowij
Journal:  Psychopharmacology (Berl)       Date:  2012-03-09       Impact factor: 4.530

5.  High times for low-frequency stimulation as endocannabinoids engage in hippocampal long-term depression.

Authors:  Sachin Patel
Journal:  Neuropsychopharmacology       Date:  2012-02       Impact factor: 7.853

6.  Moving bliss: a new anandamide transporter.

Authors:  Giovanni Marsicano; Francis Chaouloff
Journal:  Nat Neurosci       Date:  2011-12-23       Impact factor: 24.884

7.  An 'exciting' spin on cannabinoid signalling.

Authors:  Eric S Levine
Journal:  J Physiol       Date:  2011-11-15       Impact factor: 5.182

8.  A biophysically-based neuromorphic model of spike rate- and timing-dependent plasticity.

Authors:  Guy Rachmuth; Harel Z Shouval; Mark F Bear; Chi-Sang Poon
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-16       Impact factor: 11.205

9.  Action potential-triggered somatic exocytosis in mesencephalic trigeminal nucleus neurons in rat brain slices.

Authors:  Bo Zhang; Xiao-Yu Zhang; Pi-Fu Luo; Wei Huang; Fei-Peng Zhu; Tao Liu; Yi-Ru Du; Qi-Hui Wu; Jin Lü; Yun Xiu; Li-Na Liu; Hong-Ping Huang; Shu Guo; Hui Zheng; Claire Xi Zhang; Zhuan Zhou
Journal:  J Physiol       Date:  2011-11-28       Impact factor: 5.182

Review 10.  Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome.

Authors:  Elizabeth M Berry-Kravis; Lothar Lindemann; Aia E Jønch; George Apostol; Mark F Bear; Randall L Carpenter; Jacqueline N Crawley; Aurore Curie; Vincent Des Portes; Farah Hossain; Fabrizio Gasparini; Baltazar Gomez-Mancilla; David Hessl; Eva Loth; Sebastian H Scharf; Paul P Wang; Florian Von Raison; Randi Hagerman; Will Spooren; Sébastien Jacquemont
Journal:  Nat Rev Drug Discov       Date:  2017-12-08       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.